Siro Simizu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Siro Simizu has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
Takehiro Suzuki
Biomolecular Characterization Unit RIKEN Center for Sustainable Resource Science Wako Japan
20 shared publicationsNaoshi Dohmae
Biomolecular Characterization Unit RIKEN Center for Sustainable Resource Science Wako Japan
19 shared publicationsYukiko Sasazawa
Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan
13 shared publications- Yuki Niwa
Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, 565-0871, Japan
12 shared publications - Kazuki Miura
School of Life Science and Technology, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan
10 shared publications Ryota Kawahara
Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan
9 shared publications
Latest Publications
- 9 October 2026
- Published by Springer Nature in The Journal of Antibiotics
- p. 1-6
Inhibition of vasculogenic mimicry by 22-benzyloxydaphlongaminone via glycolysis suppression
Vasculogenic mimicry (VM) is a phenomenon in which tumor cells themselves form vascular-like tubular structures within the tumor. Identification of novel VM inhibitors is an important research subject in tumor biology. In this study, we focused on 22-benzyloxydaphlongaminone (22-BDO), a synthetic intermediate of isodaphlongamine H. We investigated its effects on VM formation and the underlying mechanism of action. We found that 22-BDO treatment suppressed VM formation in lung adenocarcinoma A549 cells. ChemProteoBase analysis revealed decreased expression of the glycolytic enzymes aldolase A and enolase 1 following 22-BDO treatment, with glycolysis-related proteins showing an overall downward trend. In contrast, no clear similarity to known compounds was observed, suggesting that 22-BDO has a novel mode of action. Furthermore, 22-BDO reduced intracellular ATP levels, and the inhibitory activity correlated with the antiproliferative activity observed for isodaphlongamine H and its synthetic intermediates. Cell death induced by 22-BDO was partially suppressed by the addition of sodium pyruvate. In addition, 2-deoxy-D-glucose also suppressed VM formation, suggesting that energy metabolic pathways, including glycolysis, are involved in VM formation. Taken together, these findings identify 22-BDO as a novel inhibitor of VM formation and suggest an association between metabolic alterations and VM suppression.
- 9 October 2026
- Published by Springer Nature in The Journal of Antibiotics
- p. 1-6
Inhibition of vasculogenic mimicry by 22-benzyloxydaphlongaminone via glycolysis suppression
Vasculogenic mimicry (VM) is a phenomenon in which tumor cells themselves form vascular-like tubular structures within the tumor. Identification of novel VM inhibitors is an important research subject in tumor biology. In this study, we focused on 22-benzyloxydaphlongaminone (22-BDO), a synthetic intermediate of isodaphlongamine H. We investigated its effects on VM formation and the underlying mechanism of action. We found that 22-BDO treatment suppressed VM formation in lung adenocarcinoma A549 cells. ChemProteoBase analysis revealed decreased expression of the glycolytic enzymes aldolase A and enolase 1 following 22-BDO treatment, with glycolysis-related proteins showing an overall downward trend. In contrast, no clear similarity to known compounds was observed, suggesting that 22-BDO has a novel mode of action. Furthermore, 22-BDO reduced intracellular ATP levels, and the inhibitory activity correlated with the antiproliferative activity observed for isodaphlongamine H and its synthetic intermediates. Cell death induced by 22-BDO was partially suppressed by the addition of sodium pyruvate. In addition, 2-deoxy-D-glucose also suppressed VM formation, suggesting that energy metabolic pathways, including glycolysis, are involved in VM formation. Taken together, these findings identify 22-BDO as a novel inhibitor of VM formation and suggest an association between metabolic alterations and VM suppression.
- Open Access
- 15 April 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1870 (7) , 130954
Limited involvement of MMP2, MMP9 and MMP14 in vasculogenic mimicry formation of human tumor cell lines
- 15 April 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1870 (7) , 130954
Open AccessLimited involvement of MMP2, MMP9 and MMP14 in vasculogenic mimicry formation of human tumor cell lines
- Open Access
- 20 February 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 809, 153510
C-mannosyltransferase Dpy19l1l regulates body axis formation via secretion of SCO-spondin in zebrafish
- 20 February 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 809, 153510
Open AccessC-mannosyltransferase Dpy19l1l regulates body axis formation via secretion of SCO-spondin in zebrafish
- Open Access
- 27 August 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (10) , 110635
Loss of angulin-1/LSR promotes vasculogenic mimicry and epithelial-mesenchymal transition in breast cancer
- 27 August 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (10) , 110635
Open AccessLoss of angulin-1/LSR promotes vasculogenic mimicry and epithelial-mesenchymal transition in breast cancer
- Open Access
- 6 August 2025
- Published by Wiley in FEBS Letters
- Vol. 599 (21) , 3113-3123
C ‐mannosylation promotes ADAMTS1 activation and secretion in human testicular germ cell tumor NEC8 cells
C ‐mannosylation is a protein glycosylation that regulates the functions of target proteins. Although it has been reported that a disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1), an important spermatogenesis factor, is C ‐mannosylated, the roles of C ‐mannosylation in ADAMTS1 in testicular cells are still unclear. In this study, we found that ADAMTS1 is C ‐mannosylated at Trp 562 and Trp 565 in testis germ NEC8 cells. To determine the roles of C ‐mannosylation in ADAMTS1, we established cells expressing a C ‐mannosylation‐defective ADAMTS1, in which C ‐mannosylated tryptophan residues were replaced with phenylalanine residues (ADAMTS1/2WF). Processing and secretion of ADAMTS1/2WF were both inhibited compared to those of wild‐type. Moreover, wild‐type ADAMTS1 degraded aggrecan, whereas ADAMTS1/2WF could not. These results indicate the impact of C ‐mannosylation on ADAMTS1 function.
- 6 August 2025
- Published by Wiley in FEBS Letters
- Vol. 599 (21) , 3113-3123
Open AccessC ‐mannosylation promotes ADAMTS1 activation and secretion in human testicular germ cell tumor NEC8 cells
C ‐mannosylation is a protein glycosylation that regulates the functions of target proteins. Although it has been reported that a disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1), an important spermatogenesis factor, is C ‐mannosylated, the roles of C ‐mannosylation in ADAMTS1 in testicular cells are still unclear. In this study, we found that ADAMTS1 is C ‐mannosylated at Trp 562 and Trp 565 in testis germ NEC8 cells. To determine the roles of C ‐mannosylation in ADAMTS1, we established cells expressing a C ‐mannosylation‐defective ADAMTS1, in which C ‐mannosylated tryptophan residues were replaced with phenylalanine residues (ADAMTS1/2WF). Processing and secretion of ADAMTS1/2WF were both inhibited compared to those of wild‐type. Moreover, wild‐type ADAMTS1 degraded aggrecan, whereas ADAMTS1/2WF could not. These results indicate the impact of C ‐mannosylation on ADAMTS1 function.
- Open Access
Sensor Arrays for Electrochemical Detection of PCR-Amplified Genes Extracted from Cells Suspended in Environmental Waters
Ecological surveys of living things based on DNAs from environmental samples are attractive. However, despite simplicity of water sampling from the target environment, it is still necessary to transport the samples to the laboratory for DNA analysis based on skillful next-generation sequencers. To perform DNA-oriented surveys based on a simple protocol without any special training, we demonstrated, in this study, the detection of genes from cell-containing environmental waters using gene sensor arrays that require no DNA labeling and no external indicators. Cell-suspended PBS or river water were used as models of environmental waters containing living things, and DNA samples were prepared by PCR amplification. Ferrocene-terminated probes were synthesized and immobilized on an electrode array to develop a sensor array. The sensor array showed a large response to a target DNA complementary to the probe and no response to a mismatched DNA, indicating sequence-specific detection. For DNA samples prepared from the cells in PBS, they showed good responses similar to those for the target DNA. They also significantly detected DNA samples from the cells in river water at a general environmental concentration (38 cells mL−1) with 28-fold larger responses than those for 0 cells mL−1.
Open AccessSensor Arrays for Electrochemical Detection of PCR-Amplified Genes Extracted from Cells Suspended in Environmental Waters
Ecological surveys of living things based on DNAs from environmental samples are attractive. However, despite simplicity of water sampling from the target environment, it is still necessary to transport the samples to the laboratory for DNA analysis based on skillful next-generation sequencers. To perform DNA-oriented surveys based on a simple protocol without any special training, we demonstrated, in this study, the detection of genes from cell-containing environmental waters using gene sensor arrays that require no DNA labeling and no external indicators. Cell-suspended PBS or river water were used as models of environmental waters containing living things, and DNA samples were prepared by PCR amplification. Ferrocene-terminated probes were synthesized and immobilized on an electrode array to develop a sensor array. The sensor array showed a large response to a target DNA complementary to the probe and no response to a mismatched DNA, indicating sequence-specific detection. For DNA samples prepared from the cells in PBS, they showed good responses similar to those for the target DNA. They also significantly detected DNA samples from the cells in river water at a general environmental concentration (38 cells mL−1) with 28-fold larger responses than those for 0 cells mL−1.
- Open Access
- 30 September 2024
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 34 (11)
Identification of C-mannosylation in a receptor tyrosine kinase AXL
C-mannosylation is a unique type of glycosylation in which a mannose is added to tryptophan in a protein. However, the biological function of C-mannosylation is still largely unknown. AXL is a receptor tyrosine kinase, and its overexpression contributes to tumor malignancy. The role of AXL in cancer cells is broad, including invasion, drug resistance, and vasculogenic mimicry formation. Although Trp320 of AXL was predicted to be C-mannosylated, it has not been confirmed. Here, we demonstrated that Trp320 of AXL is C-mannosylated, measured by mass spectrometry of recombinant AXL purified from various cancer cells. Furthermore, re-expression of C-mannosylation-deficient AXL in human breast cancer MDA-MB-231 cells lacking AXL by the CRISPR/Cas9 system resulted in reduction of vasculogenic mimicry formation. Interestingly, phosphorylation levels of AKT in C-mannosylation-deficient AXL re-expressing cells were comparable to those of parental and wild-type AXL re-expressing cells. These results represent the first discovery of C-mannosylation in a receptor tyrosine kinase and the possibility that C-mannosylation may affect AXL function, distinct from its downstream signaling in cancer cells.
- 30 September 2024
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 34 (11)
Open AccessIdentification of C-mannosylation in a receptor tyrosine kinase AXL
C-mannosylation is a unique type of glycosylation in which a mannose is added to tryptophan in a protein. However, the biological function of C-mannosylation is still largely unknown. AXL is a receptor tyrosine kinase, and its overexpression contributes to tumor malignancy. The role of AXL in cancer cells is broad, including invasion, drug resistance, and vasculogenic mimicry formation. Although Trp320 of AXL was predicted to be C-mannosylated, it has not been confirmed. Here, we demonstrated that Trp320 of AXL is C-mannosylated, measured by mass spectrometry of recombinant AXL purified from various cancer cells. Furthermore, re-expression of C-mannosylation-deficient AXL in human breast cancer MDA-MB-231 cells lacking AXL by the CRISPR/Cas9 system resulted in reduction of vasculogenic mimicry formation. Interestingly, phosphorylation levels of AKT in C-mannosylation-deficient AXL re-expressing cells were comparable to those of parental and wild-type AXL re-expressing cells. These results represent the first discovery of C-mannosylation in a receptor tyrosine kinase and the possibility that C-mannosylation may affect AXL function, distinct from its downstream signaling in cancer cells.
- 22 March 2024
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 104, 129713
Antiproliferative activities through accelerating autophagic flux by basidalin and its analogs in human cancer cells
- 22 March 2024
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 104, 129713
Antiproliferative activities through accelerating autophagic flux by basidalin and its analogs in human cancer cells
- Open Access
- 1 January 2024
- Published by Tech Science Press in Oncology Research
- Vol. 32 (4) , 607-614
DPY19L3 promotes vasculogenic mimicry by its C-mannosyltransferase activity
C-mannosylation is a post-translational modification that occurs intracellularly in the endoplasmic reticulum. In humans, biosynthesis of C-mannosylation in proteins containing thrombospondin type 1 repeat is catalyzed by the DPY19 family; nonetheless, biological functions of protein C-mannosylation are not yet fully understood, especially in tumor progression. Vasculogenic mimicry (VM) is the formation of fluid-conducting channels by highly invasive and genetically deregulated tumor cells, enabling the tumors to form matrix-embedded vasculogenic structures, containing plasma and blood cells to meet the metabolic demands of rapidly growing tumors. In this study, we focused on DPY19L3, a C-mannosyltransferase, and aimed to unravel its role in VM. Knockout of DPY19L3 inhibited the formation of VM in HT1080 human fibrosarcoma cells. Re-expression of wild-type DPY19L3 recovered VM formation; however, DPY19L3 isoform2, an enzymatic activity-defect mutant, did not restore it, suggesting that the C-mannosyltransferase activity of DPY19L3 is crucial to its function. Furthermore, the knockdown of DPY19L3 in MDA-MB-231 breast cancer cells hindered its network formation ability. Altogether, our findings suggest that DPY19L3 is required for VM formation and stipulate the relevance of C-mannosylation in oncogenesis.
- 1 January 2024
- Published by Tech Science Press in Oncology Research
- Vol. 32 (4) , 607-614
Open AccessDPY19L3 promotes vasculogenic mimicry by its C-mannosyltransferase activity
C-mannosylation is a post-translational modification that occurs intracellularly in the endoplasmic reticulum. In humans, biosynthesis of C-mannosylation in proteins containing thrombospondin type 1 repeat is catalyzed by the DPY19 family; nonetheless, biological functions of protein C-mannosylation are not yet fully understood, especially in tumor progression. Vasculogenic mimicry (VM) is the formation of fluid-conducting channels by highly invasive and genetically deregulated tumor cells, enabling the tumors to form matrix-embedded vasculogenic structures, containing plasma and blood cells to meet the metabolic demands of rapidly growing tumors. In this study, we focused on DPY19L3, a C-mannosyltransferase, and aimed to unravel its role in VM. Knockout of DPY19L3 inhibited the formation of VM in HT1080 human fibrosarcoma cells. Re-expression of wild-type DPY19L3 recovered VM formation; however, DPY19L3 isoform2, an enzymatic activity-defect mutant, did not restore it, suggesting that the C-mannosyltransferase activity of DPY19L3 is crucial to its function. Furthermore, the knockdown of DPY19L3 in MDA-MB-231 breast cancer cells hindered its network formation ability. Altogether, our findings suggest that DPY19L3 is required for VM formation and stipulate the relevance of C-mannosylation in oncogenesis.
- 23 December 2023
- Published by Springer Nature in Analytical Sciences
- Vol. 40 (3) , 501-510
Simplified capture, extraction, and amplification of cellular DNA from water samples
DNA analysis in water samples is attracting attention in various fields. However, conventional methods for DNA analysis require a work-intensive and time-consuming sample pre-treatment. In this study, a simplified pre-treatment method for analyzing DNA in water samples was evaluated. The process consists of filtration, DNA extraction, and amplification, which can be achieved within a short time. In the filtration process, two types of filters, firstly a tissue paper (Kimwipe) and then a glass filter (GF/F), were used in sequence. The first large pore size filter enabled a reduction in filtration time by removing large particulate matter impurities present in river water matrix. Cells spiked into 1 L of river water were recovered at more than 90% within approximately 5 min filtration time. Also, DNA was extracted from the captured cells directly on the surface of the filter in only 5 min. Thus, DNA collection and extraction from a water sample can be completed within about 10 min. Furthermore, PCR amplification was performed directly from DNA-attached filter sections, which greatly reduced the number of required pre-treatment steps. Finally, we succeeded in establishing a simple and fast on-site pre-treatment system by using a hand-driven syringe filtration method. This pre-treatment system is expected to offer the possibility for the future establishment of a rapid and easy DNA analysis method applicable to various types of water samples. Graphical abstract
- 23 December 2023
- Published by Springer Nature in Analytical Sciences
- Vol. 40 (3) , 501-510
Simplified capture, extraction, and amplification of cellular DNA from water samples
DNA analysis in water samples is attracting attention in various fields. However, conventional methods for DNA analysis require a work-intensive and time-consuming sample pre-treatment. In this study, a simplified pre-treatment method for analyzing DNA in water samples was evaluated. The process consists of filtration, DNA extraction, and amplification, which can be achieved within a short time. In the filtration process, two types of filters, firstly a tissue paper (Kimwipe) and then a glass filter (GF/F), were used in sequence. The first large pore size filter enabled a reduction in filtration time by removing large particulate matter impurities present in river water matrix. Cells spiked into 1 L of river water were recovered at more than 90% within approximately 5 min filtration time. Also, DNA was extracted from the captured cells directly on the surface of the filter in only 5 min. Thus, DNA collection and extraction from a water sample can be completed within about 10 min. Furthermore, PCR amplification was performed directly from DNA-attached filter sections, which greatly reduced the number of required pre-treatment steps. Finally, we succeeded in establishing a simple and fast on-site pre-treatment system by using a hand-driven syringe filtration method. This pre-treatment system is expected to offer the possibility for the future establishment of a rapid and easy DNA analysis method applicable to various types of water samples. Graphical abstract